GAS5 and neoplasm: Accordingly, compared with the control group, tumor weight in the GAS5 overexpression group showed a significant decrease after 4 weeks, while either miR-27a-5p overexpression or sh-CYLD could reverse the inhibitory effect of GAS5 on tumor weight (Figure 6c).